Metabolic Research Institute in West Palm Beach Florida is currently enrolling adult volunteers who have been diagnosed with Fatty Liver Disease and fibrosis (NASH) in a clinical trial. This study is researching how effective an investigational study drug is at helping people with confirmed or suspected NASH and fibrosis.
Qualified candidates will: • be men or women 18 years of age or older • have a confirmed diagnosis of non-alcoholic fatty liver & fibrosis • have no current history of drug abuse or excessive alcohol consumption Additional eligibility criteria also apply.
Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
For more information call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/nash-clinical-trial/
This study is researching how effective an investigational study drug is at helping people with confirmed or suspected NASH and fibrosis. Other study requirements apply.
Study participants receive at no cost:
• Possible access to the study drug • Some participants will receive placebo, which has no active ingredients • Study support and monitoring by a healthcare team • Education about NASH and fibrosis • The opportunity to help advance NASH research
For more information, or to learn if you may qualify to participate in this study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/nash-clinical-trial
Living with Fatty Liver Disease (NASH)? Join the search for an effective treatment therapy Clinical Study Enrolling Now
For adults diagnosed with (or suspected of having) nonalcoholic fatty liver disease, this clinical research study may be of interest to you.
We are looking for adults ages 18 -75 years who have been diagnosed with nonalcoholic fatty liver disease (NASH).
The NASH-FXR clinical research study will evaluate the safety and efficacy of an investigational drug for nonalcoholic liver disease (NASH).
For more information, or to learn if you may qualify to participate in this study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/nash-fxr-study/
If you’re struggling to lose weight on your own, you may be interested in participating in the SURMOUNT-3 Study. In addition to a potential new investigational weight management option, study participants will also receive counseling and support to make healthier choices.
Qualified candidates will be men and women 18 years of age or older with no history of Diabetes (Type 1 or Type 2). Additional eligibility criteria also apply.
Study participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute: (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/weight-loss-study/
Learn about an investigational drug for nonalcoholic steatohepatitis (NASH) in the NASH-FXR study.
Study qualification requirements • 18-75 years old • Confirmed or suspected NASH diagnosis. Study staff will confirm if you have NASH during the pre-screening part of the study • No current drug abuse or excessive alcohol consumption Other requirements will apply.
Qualified participants will receive at no cost: • Potential access to the investigational study drug • Study-related support and monitoring by a healthcare team • Education about NASH • Reimbursement for time and travel
For more information about the NASH FXR study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/nash-fxr-study/
2. Insulin Study for Type 2 Diabetes using Continuous Glucose Monitoring (CGM)
3. Insulin Study for Type 2 Diabetes comparing a once-weekly study drug to insulin, in patients with type 2 diabetes
4. Oral Insulin for Type 2 Diabetes
5. Clinical trial evaluating use of the Freestyle Libre 2 Flash Glucose Monitoring System in Type 2 Diabetes
6. A once-weekly investigative insulin in the treatment of Type 2 Diabetes
7. Diabetes Peripheral Neuropathy (DPN) study for Type 1 and Type 2 Diabetes
There is no cost to participate in these research studies, and health insurance is not required.
Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
*We respect your privacy. All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential except as required by law. In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a member of the clinical study team to discuss research opportunities available to you.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.
